Therabel Coruno® molsidomine Angina Marketed
Ratiopharm diclofenac-ratiopharm-uno diclofenac Arthritis Marketed
Roche Madopar DR® levodopa/benserazide Parkinson's disease Marketed
GlaxoSmithKline Paxil CR™ paroxetine CNS Marketed
GlaxoSmithKline Requip® once-a-day(EU) ropinirole Parkinson's disease Approved
Sciele Pharma Triglide® fenofibrate Cardiovascular Marketed
Sanofi-Aventis Xatral® OD/Uroxatral® alfuzosin BPH(urinary symptoms)± Marketed
Critical Therapeutics ZYFLO CR™ zileuton Asthma Marketed
Nitec Lodotra™ prednisone Pain/Inflammation Filed
Sciele Pharma sular® nisoldipine Hypertension Marketed
Somnus Therapeutics SKP-1041 undisclosed Sleep disorders Phase I
Available SKP-1032 undisclosed Pain/inflammation Phase I
Novartis Foradil® Certihaler™ formoterol Asthma Approved
AstraZeneca Pulmicort® HFA-MDI budesonide Asthma Marketed
Abbott/Mundipharma Flutiform™ formoterol/fluticasone Asthma/COPD Phase III
Nycomed/Almirall Solaraze® diclofenac Actinic keratosis Marketed

Copyright (C) 2002, SkyePharma, All Rights Reserved